A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new ...

"And we're not used to having somebody without a career at stake in the room at a senior level," said Hudson.

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...

XtalPi Holdings, an artificial intelligence (AI) drug discovery firm based in the Greater Bay Area, is changing the ...

Many of the most devastating infectious diseases are caused by RNA viruses, and Model Medicines is working on one compound to ...

Drugmakers, academics and logistics professionals are using artificial intelligence to address the industry’s most pressing ...

We recently compiled a list of the Blackrock’s 30 Most Important AI Stocks. In this article, we are going to take a look at ...

Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.